Efficacy and Safety of VAH as a Bridging Regimen to Allo-HCT in Relapsed/Refractory AML

NCT07091006 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
44
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Ruijin Hospital